Certain cancers are rising, and some seem to be presenting at later stages, but calling this “turbo cancer” is weak framing because it lets the issue be dismissed as conspiracy.

The serious question is whether late-stage cancer presenting for the first time has increased since the pandemic, and whether this varies by cancer type, age group, immune status, or prior COVID exposure.

Patients deserve stage-specific, age-specific, and mechanism-informed research, not panic, denial, or language that helps serious questions get ignored.

Dr. Philip McMillan

Why this is important: Cancer rates climbing after the pandemic may signal a shift in how tumors behave rather than how fast they grow. This analysis links CD147, a shared doorway for the virus and aggressive cancers, to earlier invasion and spread, urging researchers to track tumors by CD147 status.

Click here to read full article…

Why this is important: A wartime experiment in the 1950s quietly upended a basic assumption, that rest speeds healing. By proving patients fared equally well while active, it showed medical tradition needs testing, not trust, seeding a discipline now ranked beside sanitation, vaccines, and antibiotics.

Click here to read full article…

Many people are experiencing fatigue, gut symptoms, abnormal liver tests, and reduced tolerance to alcohol, medications, and supplements — even when standard investigations appear relatively normal.

What’s been missing is a systems-level explanation.

Most importantly, you’ll gain access to the framework and data analysis needed to understand the patterns for yourself.

👉 Explore the full course here >

🚥 Antibodies From Long COVID Patients Triggered the Same Symptoms in Healthy Mice, Confirming an Autoimmune Driver: For millions left debilitated after COVID-19, this work pinpoints a concrete target: rogue antibodies turning the immune system against the body. By reproducing patients' pain in mice, researchers point toward treatments already on pharmacy shelves, while raising fresh questions about blood donation safety. [SOURCE]

🚥 A Vitamin D Drug Broke Down Pancreatic Cancer's Defenses and Boosted Chemotherapy Response in an Early Trial: Pancreatic cancer resists treatment partly because a fortress of tissue blocks both drugs and immune cells. Repurposing a cheap, already approved vitamin D medication appears to dismantle that barrier, helping chemotherapy work better and hinting at a simple test to predict who benefits most. [SOURCE]

🚥 A Heart Attack Floods the Brain With a Toxic Byproduct That Fuels Depression and Anxiety: Heart attack survivors often develop depression and anxiety, which in turn raise the odds of another cardiac event. Identifying a single toxic molecule that travels from the injured heart to the brain reveals why, and points to a drug that could protect both organs at once. [SOURCE]

🚥 Staying Fit in Your 30s Predicts More Elastic, Healthier Arteries Decades Later: Cardiovascular risk is usually judged by cholesterol, yet fitness may protect the heart in ways those numbers miss. Following Swedes for nearly 30 years, researchers found that staying aerobically fit from early adulthood kept arteries supple later in life, independent of lipids, blood pressure, and weight. [SOURCE]

🚥 Frailty in Older Age Is Not a One-Way Street and Can Often Be Reversed: Frailty is often treated as an inevitable slide into dependence, yet evidence shows many older people move back toward strength. Twice-weekly resistance training, adequate protein, staying socially active, and keeping the mind engaged can rebuild the reserve that helps the body weather illness and stress.

🚥 A New Once-Daily Pill Helps Maintain Weight Loss After Stopping GLP-1 Injections: Many people regain much of their lost weight soon after stopping injectable obesity drugs. A cheaper daily pill that holds most of those losses in place, while keeping blood sugar and blood pressure improvements, could make long-term weight management more affordable and easier to sustain.